Gafson AR - Search Results

1

Neurofilaments: neurobiological foundations for biomarker applications.

Gafson AR, Barthélemy NR, Bomont P, Carare RO, Durham HD, Julien JP, Kuhle J, Leppert D, Nixon RA, Weller RO, Zetterberg H, Matthews PM. Gafson AR, et al. Brain. 2020 Jul 1;143(7):1975-1998. doi: 10.1093/brain/awaa098. Brain. 2020. PMID: 32408345 Free PMC article. Review.

2

Personalised medicine for multiple sclerosis care.

Gafson A, Craner MJ, Matthews PM. Gafson A, et al. Mult Scler. 2017 Mar;23(3):362-369. doi: 10.1177/1352458516672017. Epub 2016 Sep 28. Mult Scler. 2017. PMID: 27672137 Free article. Review.

3

Remote Monitoring in the Home Validates Clinical Gait Measures for Multiple Sclerosis.

Supratak A, Datta G, Gafson AR, Nicholas R, Guo Y, Matthews PM. Supratak A, et al. Among authors: gafson ar. Front Neurol. 2018 Jul 13;9:561. doi: 10.3389/fneur.2018.00561. eCollection 2018. Front Neurol. 2018. PMID: 30057565 Free PMC article.

4

Mononuclear cell transcriptome changes associated with dimethyl fumarate in MS.

Gafson AR, Kim K, Cencioni MT, van Hecke W, Nicholas R, Baranzini SE, Matthews PM. Gafson AR, et al. Neurol Neuroimmunol Neuroinflamm. 2018 Jun 12;5(4):e470. doi: 10.1212/NXI.0000000000000470. eCollection 2018 Jul. Neurol Neuroimmunol Neuroinflamm. 2018. PMID: 30283812 Free PMC article.

5

Lipoprotein markers associated with disability from multiple sclerosis.

Gafson AR, Thorne T, McKechnie CIJ, Jimenez B, Nicholas R, Matthews PM. Gafson AR, et al. Sci Rep. 2018 Nov 19;8(1):17026. doi: 10.1038/s41598-018-35232-7. Sci Rep. 2018. PMID: 30451923 Free PMC article.

6

Breaking the cycle: Reversal of flux in the tricarboxylic acid cycle by dimethyl fumarate.

Gafson AR, Savva C, Thorne T, David M, Gomez-Romero M, Lewis MR, Nicholas R, Heslegrave A, Zetterberg H, Matthews PM. Gafson AR, et al. Neurol Neuroimmunol Neuroinflamm. 2019 Apr 22;6(3):e562. doi: 10.1212/NXI.0000000000000562. eCollection 2019 May. Neurol Neuroimmunol Neuroinflamm. 2019. PMID: 31086805 Free PMC article.

7

Serum Neurofilament Light and Multiple Sclerosis Progression Independent of Acute Inflammation.

Gafson AR, Jiang X, Shen C, Kapoor R, Zetterberg H, Fox RJ, Belachew S. Gafson AR, et al. JAMA Netw Open. 2022 Feb 1;5(2):e2147588. doi: 10.1001/jamanetworkopen.2021.47588. JAMA Netw Open. 2022. PMID: 35133438 Free PMC article.

8

Glial fibrillary acidic protein and multiple sclerosis progression independent of acute inflammation.

Jiang X, Shen C, Teunissen CE, Wessels M, Zetterberg H, Giovannoni G, Singh CM, Caba B, Elliott C, Fisher E, de Moor C, Belachew S, Gafson AR. Jiang X, et al. Among authors: gafson ar. Mult Scler. 2023 Aug;29(9):1070-1079. doi: 10.1177/13524585231176732. Epub 2023 Jun 15. Mult Scler. 2023. PMID: 37317870 Free PMC article.

9

Precision medicine analysis of heterogeneity in individual-level treatment response to amyloid beta removal in early Alzheimer's disease.

Pang M, Gabelle A, Saha-Chaudhuri P, Huijbers W, Gafson A, Matthews PM, Tian L, Rubino I, Hughes R, de Moor C, Belachew S, Shen C. Pang M, et al. Alzheimers Dement. 2024 Feb;20(2):1102-1111. doi: 10.1002/alz.13431. Epub 2023 Oct 26. Alzheimers Dement. 2024. PMID: 37882364 Free PMC article.

10

Anti-JC virus antibody titres increase over time with natalizumab treatment.

Raffel J, Gafson AR, Malik O, Nicholas R. Raffel J, et al. Among authors: gafson ar. Mult Scler. 2015 Dec;21(14):1833-8. doi: 10.1177/1352458515599681. Epub 2015 Oct 8. Mult Scler. 2015. PMID: 26449743 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

26 results

Search Page